Some Investors May Be Willing To Look Past Lonza Group's (VTX:LONN) Soft Earnings
Apr 10
Swiss (SMI) Clinical Research and Equipment Industry Analysis
UpdatedApr 16, 2024
DataAggregated Company Financials
Companies7
- 7D-3.6%
- 3M34.8%
- 1Y-7.6%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.2%, driven by Lonza Group declining 2.1%. Overall the industry is down 7.2% in 12 months. Earnings are forecast to grow by 19% annually.
Industry Valuation and Performance
Has the Swiss Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 16 Apr 2024 | CHF55.9b | CHF10.3b | CHF1.0b | 44.2x | 55.7x | 5.4x |
| Thu, 14 Mar 2024 | CHF52.5b | CHF10.2b | CHF1.0b | 44.5x | 52.3x | 5.1x |
| Sat, 10 Feb 2024 | CHF48.1b | CHF10.2b | CHF1.0b | 42.5x | 47.2x | 4.7x |
| Mon, 08 Jan 2024 | CHF40.2b | CHF9.8b | CHF1.5b | 30.7x | 26.9x | 4.1x |
| Wed, 06 Dec 2023 | CHF39.4b | CHF9.8b | CHF1.5b | 28.9x | 26.4x | 4x |
| Fri, 03 Nov 2023 | CHF37.8b | CHF9.8b | CHF1.5b | 26.4x | 25.3x | 3.9x |
| Sun, 01 Oct 2023 | CHF46.5b | CHF9.8b | CHF1.5b | 32.2x | 31.2x | 4.8x |
| Tue, 29 Aug 2023 | CHF52.0b | CHF9.8b | CHF1.5b | 36x | 34.8x | 5.3x |
| Thu, 27 Jul 2023 | CHF52.3b | CHF9.8b | CHF1.5b | 35.8x | 33.8x | 5.3x |
| Sat, 24 Jun 2023 | CHF55.2b | CHF9.7b | CHF1.6b | 34.3x | 33.7x | 5.7x |
| Mon, 22 May 2023 | CHF60.8b | CHF9.7b | CHF1.6b | 39x | 37.2x | 6.3x |
| Wed, 19 Apr 2023 | CHF61.4b | CHF9.7b | CHF1.7b | 42.6x | 36.8x | 6.3x |
| Fri, 17 Mar 2023 | CHF56.6b | CHF9.7b | CHF1.7b | 41x | 34.2x | 5.9x |
| Sun, 12 Feb 2023 | CHF57.2b | CHF9.6b | CHF1.6b | 33.2x | 35x | 6x |
| Tue, 10 Jan 2023 | CHF51.2b | CHF9.2b | CHF1.3b | 37.7x | 38.5x | 5.6x |
| Thu, 08 Dec 2022 | CHF51.3b | CHF9.2b | CHF1.3b | 38.2x | 38.6x | 5.6x |
| Sat, 05 Nov 2022 | CHF50.4b | CHF9.2b | CHF1.3b | 39.1x | 37.9x | 5.5x |
| Mon, 03 Oct 2022 | CHF50.6b | CHF9.2b | CHF1.3b | 39.7x | 39.1x | 5.5x |
| Wed, 31 Aug 2022 | CHF54.5b | CHF9.2b | CHF1.3b | 42.9x | 42.1x | 5.9x |
| Fri, 29 Jul 2022 | CHF54.3b | CHF8.9b | CHF1.3b | 33.3x | 41.4x | 6.1x |
| Sun, 26 Jun 2022 | CHF53.3b | CHF8.5b | CHF1.1b | 46.2x | 49.4x | 6.3x |
| Tue, 24 May 2022 | CHF56.8b | CHF8.5b | CHF1.1b | 45.7x | 52.6x | 6.7x |
| Thu, 21 Apr 2022 | CHF66.3b | CHF8.5b | CHF1.1b | 58.7x | 61.4x | 7.8x |
| Sat, 19 Mar 2022 | CHF68.8b | CHF8.2b | CHF1.1b | 52.8x | 64.7x | 8.4x |
| Mon, 14 Feb 2022 | CHF65.8b | CHF8.0b | CHF1.1b | 60.9x | 62.4x | 8.2x |
| Wed, 12 Jan 2022 | CHF73.7b | CHF7.4b | CHF929.7m | 77.2x | 79.3x | 10x |
| Fri, 10 Dec 2021 | CHF80.3b | CHF7.4b | CHF918.4m | 85.9x | 87.4x | 10.9x |
| Sun, 07 Nov 2021 | CHF77.8b | CHF7.4b | CHF918.8m | 82x | 84.6x | 10.6x |
| Tue, 05 Oct 2021 | CHF75.2b | CHF7.4b | CHF919.8m | 77.2x | 81.8x | 10.2x |
| Thu, 02 Sep 2021 | CHF82.6b | CHF7.4b | CHF920.8m | 85.4x | 89.7x | 11.2x |
| Sat, 31 Jul 2021 | CHF74.2b | CHF7.4b | CHF920.8m | 62x | 80.5x | 10.1x |
| Tue, 04 May 2021 | CHF61.1b | CHF7.1b | CHF964.3m | 60.5x | 63.4x | 8.7x |
Price to Earnings Ratio
63.4x
Current Industry PE
- Investors are optimistic on the Swiss Life Sciences Tools and Services industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 55.7x which is higher than its 3-year average PE of 51.1x.
- The 3-year average PS ratio of 6.9x is higher than the industry's current PS ratio of 5.4x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 13% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does Swiss Clinical Research and Equipment compare with similar industries?
| CH Market | -1.13% | |
| Healthcare | 0.45% | |
| Life Sciences | -3.63% | |
| Clinical Research and Equipment | -3.63% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| XLS Xlife Sciences | CHF39.50 | 3.7% +CHF8.0m | 27.4% | PE14x | |
| SKAN SKAN Group | CHF81.80 | 0.4% +CHF6.7m | -2.6% | PE69.9x |
